Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Target Oncol. 2013 Feb 12;8(3):183–188. doi: 10.1007/s11523-013-0266-9

Figure 2. Imaging showing response to bevacizumab and vaproic acid in Patient 2.

Figure 2

The baseline CT of chest, abdomen and pelvis of Patient 2 shows ascites, right lung pleural based, and peritoneal metastases. After 8 weeks of therapy there is improvement in size of all lesions with resolution of ascites.